Product NDC: | 17478-714 |
Proprietary Name: | Ciprofloxacin |
Non Proprietary Name: | Ciprofloxacin Hydrochloride |
Active Ingredient(s): | 3 mg/mL & nbsp; Ciprofloxacin Hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-714 |
Labeler Name: | Akorn Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076555 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090724 |
Package NDC: | 17478-714-10 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (17478-714-10) > 5 mL in 1 BOTTLE, DROPPER |
NDC Code | 17478-714-10 |
Proprietary Name | Ciprofloxacin |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (17478-714-10) > 5 mL in 1 BOTTLE, DROPPER |
Product NDC | 17478-714 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ciprofloxacin Hydrochloride |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20090724 |
Marketing Category Name | ANDA |
Labeler Name | Akorn Inc. |
Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
Strength Number | 3 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |